Angle Share News (AGL)

ANGLE Sees Further Encouraging Results For Parsortix In Ovarian Cancer

ANGLE Says Work With Parsortix In Prostate Cancer Published In Journal

AGM, EGM Calendar - Week Ahead

ANGLE Says "Highly Promising" Parsortix Breast Cancer Results Presented

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Amazon, GM, AT&T

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

ANGLE Loss Widens As It Continues To Drive Parsortix Development

Angle posts positive prostate cancer treatment tests update

Medical diagnostic company Angle said the investigation into the clinical use of its Parsortix system in prostate cancer treatments was encouraging. Researchers from Barts Cancer Institute, which is carrying out the tests, were able to successfully harvest circulating tumor cells from all the 52 ass

ANGLE Says Prostate Cancer Study Results With Parsortix "Encouraging"

ANGLE Gets Chinese And Australian Patents For Parsotix

LONDON MIDDAY BRIEFING: Sky, ARM Hit Highs After Strong Results

ANGLE Gets Positive Results For Parsotix In Ovarian Cancer Detection

ANGLE's Parsortix System Successfully Tested, Results Published

ANGLE Raises Further GBP1.5 Million In Share Subscription (ALLISS)

UK MIDDAY BRIEFING: "Time And Money Are Running Out For Greece"